{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T21:16:18Z","timestamp":1777497378521,"version":"3.51.4"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100005329","name":"Natural Science Foundation of Guizhou Province","doi-asserted-by":"publisher","award":["QianKeHe Support [2022]181"],"award-info":[{"award-number":["QianKeHe Support [2022]181"]}],"id":[{"id":"10.13039\/501100005329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005329","name":"Natural Science Foundation of Guizhou Province","doi-asserted-by":"publisher","award":["Qiankehe Cooperation Platform talents [2021] Postdoctoral Station 007"],"award-info":[{"award-number":["Qiankehe Cooperation Platform talents [2021] Postdoctoral Station 007"]}],"id":[{"id":"10.13039\/501100005329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018555","name":"Science and Technology Program of Guizhou Province","doi-asserted-by":"publisher","award":["QianJiaoJi [2023]037"],"award-info":[{"award-number":["QianJiaoJi [2023]037"]}],"id":[{"id":"10.13039\/501100018555","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004602","name":"Program for New Century Excellent Talents in University","doi-asserted-by":"publisher","award":["gyfyxkrc-2023-14"],"award-info":[{"award-number":["gyfyxkrc-2023-14"]}],"id":[{"id":"10.13039\/501100004602","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["32270848"],"award-info":[{"award-number":["32270848"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["U23A20498"],"award-info":[{"award-number":["U23A20498"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-025-04222-8","type":"journal-article","created":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T11:09:42Z","timestamp":1740481782000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Effects of mesenchymal stem cells from different sources on the biological functions of multiple myeloma cells"],"prefix":"10.1186","volume":"16","author":[{"given":"Yanju","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinyang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoshuang","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangyang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhixu","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4297-1839","authenticated-orcid":false,"given":"Feiqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,25]]},"reference":[{"issue":"1","key":"4222_CR1","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1186\/s13287-023-03585-0","volume":"14","author":"Y Song","year":"2023","unstructured":"Song Y. Hejing Liu,Shuya Pan,et al.Emerging role of mesenchymal stromal cells in gynecologic cancer therapy. Stem Cell Res Ther. 2023;14(1):347. https:\/\/doi.org\/10.1186\/s13287-023-03585-0.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"4222_CR2","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13287-023-03245-3","volume":"14","author":"Ghaidaa Raheem Lateef Al-Awsi","year":"2023","unstructured":"Ghaidaa Raheem Lateef Al-Awsi. Fahad Alsaikhan,Ria Margiana,et al.Shining the light on mesenchymal stem cell-derived exosomes. Breast cancer Stem Cell Res Ther. 2023;14(1):21. https:\/\/doi.org\/10.1186\/s13287-023-03245-3.","journal-title":"Breast cancer Stem Cell Res Ther"},{"key":"4222_CR3","doi-asserted-by":"publisher","unstructured":"Yuan Ding C, Wang Z. Sun, Mesenchymal stem cells Engineered by Nonviral vectors:a powerful Tool in Cancer Gene Therpy.Pharmaceuti-cs.2021;13(6):913. https:\/\/doi.org\/10.3390\/pharmaceutics13060913","DOI":"10.3390\/pharmaceutics13060913"},{"issue":"1","key":"4222_CR4","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1002\/ijc.33188","volume":"148","author":"[4]Ursula Altanerova","year":"2021","unstructured":"[4]Ursula Altanerova. Jana Jakubechova,Katarina Benejova,et al.Intracellular prodrug gene therapy for cancer mediated by tumor cell suicide gene exosomes. Int J Cancer. 2021;148(1):128\u201339. https:\/\/doi.org\/10.1002\/ijc.33188.","journal-title":"Int J Cancer"},{"issue":"6","key":"4222_CR5","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.3390\/ijms23062927","volume":"23","author":"Y Guo","year":"2022","unstructured":"Guo Y, Zhai Y, Wu L, et al. Mesenchymal stem cell-derived extracellular vesicles:pleiotropic impacts on breast Cancer occurrence,Development and Therapy. Int J Mol Sci. 2022;23(6):2927. https:\/\/doi.org\/10.3390\/ijms23062927.","journal-title":"Int J Mol Sci"},{"key":"4222_CR6","doi-asserted-by":"publisher","first-page":"862524","DOI":"10.3389\/fcell.2022.862524","volume":"10","author":"J Gu","year":"2022","unstructured":"Gu J, Wang M, Wang X, et al. Exosomal mir-483-5p in bone marrow mesenchymal stem cells promotes malignant progression of multiple myeloma by targeting TIMP2. Front Cell Dev Biol. 2022;10:862524. https:\/\/doi.org\/10.3389\/fcell.2022.862524.","journal-title":"Front Cell Dev Biol"},{"issue":"12","key":"4222_CR7","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1089\/scd.2014.0254","volume":"24","author":"S Ciavarella","year":"2015","unstructured":"Ciavarella S, Caselli A, Tamma AV, et al. A peculiar molecular profile of umbilical cord-mesenchymal stromal cells drives their inhibitory effects on multiple myeloma cell growth and tumor progression. Stem Cells Dev. 2015;24(12):1457\u201370. 10.10-89\/scd.2014.0254.","journal-title":"Stem Cells Dev"},{"issue":"1","key":"4222_CR8","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s10555-022-10069-9","volume":"42","author":"Natalya Plakhova,Vasilios Panagopoulos,Kate Vandyke","year":"2023","unstructured":"Natalya Plakhova,Vasilios Panagopoulos,Kate Vandyke. Mesenchymal strom-mal cell senescence in haematological malignancies. Cancer Metastasis Rev. 2023;42(1):277\u201396. https:\/\/doi.org\/10.1007\/s10555-022-10069-9.","journal-title":"Cancer Metastasis Rev"},{"issue":"5","key":"4222_CR9","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/s41419-018-0545-6","volume":"9","author":"Y Juan Guo","year":"2018","unstructured":"Juan Guo Y, Zhao C, Fei, et al. Dicer1 downregulation by multiple myeloma cells promotes the senescence and tumor-supporting capacity and decreases the differentiation potential of mesenchymal stem cells. Cell Death Dis. 2018;9(5):512. https:\/\/doi.org\/10.1038\/s41419-018-0545-6.","journal-title":"Cell Death Dis"},{"issue":"11","key":"4222_CR10","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.3390\/jpm11111133","volume":"11","author":"S Mojsilovi\u0107","year":"2021","unstructured":"Mojsilovi\u0107 S, Jaukovi\u0107 A, Kukolj T, et al. Tumorigenic aspects of MSC Senescence-Implication in Cancer Development and Therapy. J Pers Med. 2021;11(11):1133. https:\/\/doi.org\/10.3390\/jpm11111133.","journal-title":"J Pers Med"},{"issue":"1","key":"4222_CR11","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12935-024-03304-6","volume":"24","author":"H Luo","year":"2024","unstructured":"Luo H, Pan C, Wang L, et al. Low TYROBP expression predicts poor prognosis in multiple myeloma. Cancer Cell Int. 2024;24(1):117. https:\/\/doi.org\/10.1186\/s12935-024-03304-6. PMID: 38549127; PMCID: PMC10979612.","journal-title":"Cancer Cell Int"},{"key":"4222_CR12","doi-asserted-by":"publisher","first-page":"1076815","DOI":"10.3389\/fphar.2023.1076815","volume":"14","author":"Y Li","year":"2023","unstructured":"Li Y, Yang X, Wang F, et al. Mechanism of action of Asparagus officinalis extract against multiple myeloma using bioinformatics tools, in silico and in vitro study. Front Pharmacol. 2023;14:1076815. https:\/\/doi.org\/10.3389\/fphar.2023.1076815. PMID: 37229244; PMCID: PMC10203399.","journal-title":"Front Pharmacol"},{"issue":"5","key":"4222_CR13","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1084\/jem.20051921","volume":"203","author":"AY Khakoo","year":"2006","unstructured":"Khakoo AY, Pati S, Anderson SA, et al. Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi\u2019s sarcoma. J Exp Med. 2006;203(5):1235\u201347. https:\/\/doi.org\/10.1084\/jem.20051921.","journal-title":"J Exp Med"},{"issue":"17","key":"4222_CR14","doi-asserted-by":"publisher","first-page":"8558","DOI":"10.1111\/jcmm.16817","volume":"25","author":"Y Xie","year":"2021","unstructured":"Xie Y, Chen F, Jia L, et al. Mesenchymal stem cells from different sources show distinct therapeutic effects in hyperoxia-induced bronchopulmonary dysplasia in rats. J Cell Mol Med. 2021;25(17):8558\u201366. https:\/\/doi.org\/10.1111\/jcmm.16817.","journal-title":"J Cell Mol Med"},{"issue":"2","key":"4222_CR15","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41408-020-0273-x","volume":"10","author":"MA Dimopoulos","year":"2020","unstructured":"Dimopoulos MA, Jakubowiak AJ, McCarthy PL, et al. Developments in continuous therapy and maintenance treatment approaches for patients with newly diagnosed multiple myeloma. Blood Cancer J. 2020;10(2):17. https:\/\/doi.org\/10.1038\/s41408-020-0273-x. Published 2020 Feb 13.","journal-title":"Blood Cancer J"},{"issue":"1","key":"4222_CR16","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/imr.12233","volume":"263","author":"Y Kawano","year":"2015","unstructured":"Kawano Y, Moschetta M, Manier S, et al. Targeting the bone marrow microen- vironment in multiple myeloma. Immunol Rev. 2015;263(1):160\u201372. https:\/\/doi.org\/10.1111\/imr.12233.","journal-title":"Immunol Rev"},{"issue":"1","key":"4222_CR17","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s13287-017-0655-6","volume":"8","author":"L Paola Cafforio","year":"2017","unstructured":"Paola Cafforio L, Viggiano F, Mannavola, et al. pIL-6-TRAIL-engin-eered umbilical cord mesenchymal\/stromal stem cells are highly cytotoxic for myeloma cells both in vitro and in vivo. Stem Cell Res Ther. 2017;8(1):206. https:\/\/doi.org\/10.1186\/s13287-017-0655-6.","journal-title":"Stem Cell Res Ther"},{"key":"4222_CR18","doi-asserted-by":"crossref","unstructured":"Chiara Valsecchi S, Croce A, Maltese et al. Bone marrow microenvir- onment in Light-Chain amyloidosis:in Vitro Expansion and characterization of mesenchymal stromal cell.Biomedicines.2021;9(11):1523. 10.3390","DOI":"10.3390\/biomedicines9111523"},{"issue":"2","key":"4222_CR19","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1097\/CCO.0000000000000159","volume":"27","author":"B Lee","year":"2015","unstructured":"Lee B, Sandhu S. McArthur G.Cell cycle control as a promising target in melanoma. Curr Opin Oncol. 2015;27(2):141\u201350. 10.1097.","journal-title":"Curr Opin Oncol"},{"issue":"6","key":"4222_CR20","doi-asserted-by":"publisher","first-page":"832","DOI":"10.4161\/cc.8.6.7869","volume":"8","author":"L Borgs","year":"2009","unstructured":"Borgs L, Beukelaers P, Vandenbosch R, et al. Cell circadian cycle: new role for mammalian core clock genes. Cell Cycle. 2009;8(6):832\u20137. https:\/\/doi.org\/10.4161\/cc.8.6.7869.","journal-title":"Cell Cycle"},{"issue":"9","key":"4222_CR21","doi-asserted-by":"publisher","first-page":"180112","DOI":"10.1098\/rsob.180112","volume":"8","author":"DJ Wood","year":"2018","unstructured":"Wood DJ, Endicott JA. Structural insights into the functional diversity of the CDK-cyclin family. Open Biol. 2018;8(9):180112. https:\/\/doi.org\/10.1098\/rsob.180112.","journal-title":"Open Biol"},{"issue":"7","key":"4222_CR22","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1158\/2159-8290","volume":"8","author":"F Bellutti","year":"2018","unstructured":"Bellutti F, Tigan AS, Nebenfuehr S, et al. CDK6 antagonizes p53-Induced responses during Tumorigenesis. Cancer Discov. 2018;8(7):884\u201397. https:\/\/doi.org\/10.1158\/2159-8290.","journal-title":"Cancer Discov"},{"issue":"5","key":"4222_CR23","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1182\/blood-2013-08-524025","volume":"123","author":"T Tanno","year":"2014","unstructured":"Tanno T, Lim Y, Wang Q, et al. Growth differentiating factor 15 enhances the tumor-initiating and self-renewal potential of multiple myeloma cells. Blood. 2014;123(5):725\u201333. https:\/\/doi.org\/10.1182\/blood-2013-08-524025.","journal-title":"Blood"},{"issue":"20","key":"4222_CR24","doi-asserted-by":"publisher","first-page":"7624","DOI":"10.3390\/ijms21207624","volume":"21","author":"O Ilona Kaszak","year":"2020","unstructured":"Ilona Kaszak O, Witkowska-Pi\u0142aszewicz Z, Niewiadomska, et al. Role of cadherins in Cancer-A Review. Int J Mol Sci. 2020;21(20):7624. https:\/\/doi.org\/10.3390\/ijms21207624.","journal-title":"Int J Mol Sci"},{"key":"4222_CR25","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12943-016-0502-x","volume":"15","author":"SJ Serrano-Gomez","year":"2016","unstructured":"Serrano-Gomez SJ, Maziveyi M, Alahari SK. Regulation of epithelial-mesenchmal transition through epigenetic and post-translational modifications. Mol Cancer. 2016;15:18. https:\/\/doi.org\/10.1186\/s12943-016-0502-x.","journal-title":"Mol Cancer"},{"key":"4222_CR26","doi-asserted-by":"publisher","unstructured":"Li X, Luo X, He Y, et al. Micronano titanium accelerates mesenchymal stem cells aging through the activation of senescence-associated secretory. Phenotype ACS Nano. 2023;17(22):22885\u2013900. https:\/\/doi.org\/10.1021\/acsnano.3c07807.","DOI":"10.1021\/acsnano.3c07807"},{"issue":"4","key":"4222_CR27","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. Int Soc Cell Therapy Position Statement Cytotherapy. 2006;8(4):315\u20137. https:\/\/doi.org\/10.1080\/14653240600855905.","journal-title":"Int Soc Cell Therapy Position Statement Cytotherapy"},{"key":"4222_CR28","doi-asserted-by":"publisher","first-page":"65","DOI":"10.5483\/BMBRep.2020.53.2.291","volume":"53","author":"BC Lee","year":"2020","unstructured":"Lee BC, Yu K. R.Impact of mesenchymal stem cell senescence on inflammaging. BMB Rep. 2020;53:65\u201373. https:\/\/doi.org\/10.5483\/BMBRep.2020.53.2.291.","journal-title":"BMB Rep"},{"issue":"3","key":"4222_CR29","doi-asserted-by":"publisher","first-page":"e12933","DOI":"10.1111\/acel.12933","volume":"18","author":"D Gnani","year":"2019","unstructured":"Gnani D, Crippa S, Della Volpe L, et al. An early-senescence state in aged mesen-chymal stromal cells contributes to hematopoietic stem and progenitor cell clonogenic impairment through the activation of a pro-inflammatory program. Aging Cell. 2019;18(3):e12933. https:\/\/doi.org\/10.1111\/acel.12933.","journal-title":"Aging Cell"},{"issue":"1","key":"4222_CR30","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s12032-009-9403-9","volume":"28","author":"M Kowalska","year":"2011","unstructured":"Kowalska M, Kaminska J, Fuksiewicz M, et al. A survey of prognostic value of serum factors in multiple myeloma patients before treatment: macrophage-colony stimulating factor (M-CSF) is a powerful predictor of survival. Med Oncol. 2011;28(1):194\u20138. https:\/\/doi.org\/10.1007\/s12032-009-9403-9.","journal-title":"Med Oncol"},{"issue":"3","key":"4222_CR31","doi-asserted-by":"publisher","first-page":"e58504","DOI":"10.1371\/journal.pone.0058504","volume":"8","author":"MM Zheng","year":"2013","unstructured":"Zheng MM, Zhang Z, Bemis K, et al. The systemic cytokine environment is permanently altered in multiple myeloma. PLoS ONE. 2013;8(3):e58504. https:\/\/doi.org\/10.1371\/journal.pone.0058504.","journal-title":"PLoS ONE"},{"issue":"9","key":"4222_CR32","doi-asserted-by":"publisher","first-page":"4462","DOI":"10.3390\/ijms22094462","volume":"22","author":"N Giannakoulas","year":"2021","unstructured":"Giannakoulas N, Ntanasis-Stathopoulos I, Terpos E. The role of Marrow Micro-environment in the growth and development of malignant plasma cells in multiple myeloma. Int J Mol Sci. 2021;22(9):4462. https:\/\/doi.org\/10.3390\/ijms22094462.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"4222_CR33","doi-asserted-by":"publisher","first-page":"421","DOI":"10.4252\/wjsc.v15.i5.421","volume":"15","author":"A Daniel Garc\u00eda-S\u00e1nchez","year":"2023","unstructured":"Daniel Garc\u00eda-S\u00e1nchez A, Gonz\u00e1lez-Gonz\u00e1lez. Ana Alfonso-Fern\u00e1ndez,e t al.Communication between bone marrow mesenchymal stem cells and multiple myeloma cells: impact on disease progression.World. J Stem Cells. 2023;15(5):421\u201337. https:\/\/doi.org\/10.4252\/wjsc.v15.i5.421.","journal-title":"J Stem Cells"},{"key":"4222_CR34","doi-asserted-by":"publisher","unstructured":"Shivali Jasrotia R, Gupta A, Sharma et al. Cytokine profile in multiple myeloma.Cytokine.2020;136:155271.https:\/\/doi.org\/10.1016\/j.cyto.2020.155271","DOI":"10.1016\/j.cyto.2020.155271"},{"issue":"18","key":"4222_CR35","doi-asserted-by":"publisher","first-page":"4679","DOI":"10.1158\/0008-5472.CAN-19-0343","volume":"79","author":"PSY Chong","year":"2019","unstructured":"Chong PSY, Zhou J, Lim JSL, et al. IL-6 promotes a STAT3-PRL3 Feedforward Loop via SHP2 repression in multiple myeloma. Cancer Res. 2019;79(18):4679\u201388. https:\/\/doi.org\/10.1158\/0008-5472.CAN-19-0343.","journal-title":"Cancer Res"},{"issue":"1","key":"4222_CR36","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3892\/mmr.2020.11691","volume":"23","author":"M Liu","year":"2021","unstructured":"Liu M, Liu H, Zhou J, et al. miR\u2013140\u20135p inhibits the proliferation of multiple myeloma cells by targeting VEGFA. Mol Med Rep. 2021;23(1):53. https:\/\/doi.org\/10.3892\/mmr.2020.11691.","journal-title":"Mol Med Rep"},{"issue":"12","key":"4222_CR37","doi-asserted-by":"publisher","first-page":"e511","DOI":"10.1038\/bcj.2016.118","volume":"6","author":"C Botta","year":"2016","unstructured":"Botta C, Di Martino MT, Ciliberto D, et al. A gene expression inflammatory signature specifically predicts multiple myeloma evolution and patients survival. Blood Cancer J. 2016;6(12):e511. https:\/\/doi.org\/10.1038\/bcj.2016.118.","journal-title":"Blood Cancer J"},{"key":"4222_CR38","doi-asserted-by":"crossref","unstructured":"Gu J, Huang X, Zhang Y et al. Cytokine profiles in patients with newly diagnosed multiple myeloma: survival is associated with IL-6 and IL-17A levels.Cytokine. 2021;138:15535810.1016\/j.cyto.2020.155358","DOI":"10.1016\/j.cyto.2020.155358"},{"key":"4222_CR39","doi-asserted-by":"publisher","first-page":"788","DOI":"10.3389\/fendo.2018.00788","volume":"9","author":"D Harmer","year":"2019","unstructured":"Harmer D, Falank C, Reagan MR. Interleukin-6 interweaves the bone marrow microenvironment, bone loss, and multiple myeloma. Front Endocrinol (Lausanne). 2019;9:788. https:\/\/doi.org\/10.3389\/fendo.2018.00788.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"4222_CR40","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1038\/sj.bjc.6601613","volume":"90","author":"E Menu","year":"2004","unstructured":"Menu E, Kooijman R, Van Valckenborgh E, et al. Specific roles for the PI3K and the MEK-ERK pathway in IGF-1-stimulated chemotaxis, VEGF secretion and proliferation of multiple myeloma cells: study in the 5T33MM model. Br J Cancer. 2004;90(5):1076\u201383. https:\/\/doi.org\/10.1038\/sj.bjc.6601613.","journal-title":"Br J Cancer"},{"issue":"7","key":"4222_CR41","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1158\/2159-8290.CD-17-0912","volume":"8","author":"F Bellutti","year":"2018","unstructured":"Bellutti F, Tigan AS, Nebenfuehr S, et al. CDK6 antagonizes p53-Induced Respo-nses during Tumorigenesis. Cancer Discov. 2018;8(7):884\u201397. https:\/\/doi.org\/10.1158\/2159-8290.CD-17-0912.","journal-title":"Cancer Discov"},{"key":"4222_CR42","doi-asserted-by":"publisher","unstructured":"Heinemann L, M\u00f6llers KM, Ahmed HMM, et al. Inhibiting PI3K-AKT-mTOR signaling in multiple myeloma-Associated Mesenchymal stem cells impedes the proliferation of multiple myeloma cells. Front Oncol. 2022;12. https:\/\/doi.org\/10.3389\/fonc.2022.874325.","DOI":"10.3389\/fonc.2022.874325"},{"key":"4222_CR43","doi-asserted-by":"crossref","unstructured":"Bariana M, Cassella E, Rateshwar J, et al. Inhibition of NF-\u0198B DNA binding suppresses Myeloma Growth via Intracellular Redox and Tumor Microenvironment Modulation. Mol Cancer Ther. 2022;21(12):1798\u2013809. https:\/\/www.doi.org\/10.1158\/1535-7163.MCT-22\u20130257.","DOI":"10.1158\/1535-7163.MCT-22-0257"},{"issue":"1","key":"4222_CR44","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2174\/1871520619666191024115738","volume":"20","author":"S Ranjani","year":"2020","unstructured":"Ranjani S, Kowshik J, Sophia J, et al. Activation of PI3K\/Akt\/NF-\u03baB signaling mediates Swedish Snus Induced Proliferation and apoptosis evasion in the Rat Forestomach: modulation by Blueberry. Anticancer Agents Med Chem. 2020;20(1):59\u201369. https:\/\/doi.org\/10.2174\/1871520619666191024115738.","journal-title":"Anticancer Agents Med Chem"},{"key":"4222_CR45","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.lfs.2020.117503","volume":"249","author":"Y Peng","year":"2022","unstructured":"Peng Y, Li F, Zhang P, et al. IGF-1 promotes multiple myeloma progression through PI3K\/Akt-mediated epithelial-mesenchymal transition. Life Sci. 2022;249:117\u2013503. https:\/\/doi.org\/10.1016\/j.lfs.2020.117503.","journal-title":"Life Sci"},{"key":"4222_CR46","doi-asserted-by":"publisher","first-page":"110909doi","DOI":"10.1016\/j.biopha.2020.110909","volume":"133","author":"G Babaei","year":"2021","unstructured":"Babaei G, Aziz SG, Jaghi NZZ. EMT, cancer stem cells and autophagy; the three main axes of metastasis. Biomed Pharmacother. 2021;133:110909doi. https:\/\/doi.org\/10.1016\/j.biopha.2020.110909.","journal-title":"Biomed Pharmacother"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04222-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-025-04222-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04222-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T11:09:49Z","timestamp":1740481789000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-025-04222-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,25]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4222"],"URL":"https:\/\/doi.org\/10.1186\/s13287-025-04222-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4782931\/v1","asserted-by":"object"}]},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,25]]},"assertion":[{"value":"14 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Title of the research approval project: Mechanism study of the effect of mesenchymal stem cells in different source states on multiple myeloma, approved by the Medical Ethics Committee of the Affiliated Hospital of Guizhou Medical University, approval number: 2023 Lun Review No. (507), approval time is June 15, 2023. In this study a total of five donors, donors signed informed consent between July 2023 and May 2024. The original source has confirmed that there was initial ethical approval for collection of human cells, and that the donors had signed informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the authors contributed to the data acquisition and analyses. All the authors have reviewed and approved of the final version of the manuscript and consent to publish.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no conflicts of interest to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"89"}}